1 day ago – … from indolent lymphoma) or high-grade B-cell lymphoma with MYC and BCL2
and/or BCL6 rearrangements, 1 line of prior systemic therapy, previous stem cell transplant >…
ABCL-351 LOTIS-5, an Ongoing, Phase 3 Randomized Study of Loncastuximab Tesirine With Rituximab (Lonca-R) Versus Immunochemotherapy in Patients With R/R …
Published: 08/28/2024